产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 178118 | 雷尼司他 | 147254-64-6 | 98.0% |  |
| 雷尼司他,也被称为AS-3201、SX-3201,是一种醛糖还原酶抑制剂，由Dai | ||||
| 174192 | RG7800 ( RO6885247 ) | 1449598-06-4 | ≧98.0% | _1449598-06-4.png) |
| RG7800(RO6885247)是一种小分子改变生存运动神经元2的拼接。 | ||||
| 17030609 | 罗拉吡坦盐酸盐 | 914462-92-3 | 98% |  |
| 罗拉吡坦, 也被称为SCH-619734是一种用于口服的，具有中央作用，选 | ||||
| 17030605 | RAF709 | 1628838-42-5 | 98% |  |
| RAF709是一种Raf激酶抑制剂。 | ||||
| 17030301 | RPI-1 | 269730-03-2 | 98% |  |
| RPI-1是一种ATP依赖的RET激酶抑制剂。通过口服RPI-1，导致生长阻滞 | ||||
| 17022712 | Recilisib钠盐 | 334969-03-8 | 98% |  |
| Recilisib，也被称为 ON 01210钠，是一种放射性保护剂，它可以在接受 | ||||
| 17011603 | RO4987655 | 874101-00-5 | 98% |  |
| RO4987655,也称为CH4987655, 是一种口服活性的小分子，靶向活性蛋白激 | ||||
| 17011602 | Ro 08-2750 | 37854-59-4 | 98% |  |
| Ro 08-2750是一个强有力的和选择性的神经生长因子(神经生长因子)抑 | ||||
| 17011305 | Ribociclib HCl | 1211443-80-9 | 98% |  |
| Ribociclib HCl是一种有效且可口服的细胞周期蛋白依赖性激酶(CDK)抑 | ||||
| 17011303 | 雷替曲塞 | 112887-68-0 | 98% |  |
| 雷替曲塞,也称为ZD 1694, 是1998年以来用于治疗结直肠癌的一种抗代 | ||||
| 17011108 | 瑞替加滨 | 150812-13-8 | 98% |  |
| 瑞替加滨是一种新型的抗惊厥剂，具有活动范围广泛的癫痫模型。 | ||||
| 17109007 | RO9021 | 1446790-62-0 | 98% | |
| RO9021能有效抑制SYK激酶活性，平均IC50为5.6 nM，抑制b细胞受体信号 | ||||
| 1710902 | Rbin-1 | 328023-11-6 | 98% |  |
| Rbin-1(ribozinoindole-1)是真核核糖体的一种有效的化学抑制剂。它抑制 | ||||
| 16122773 | ReACp53 | 98% |  | |
| ReACp53 is a cell-penetrating peptide, designed to inhibit p53 amyloid formation, res | ||||
| 6111503 | RU-SKI 43 | 1043797-53-0 | 98% |  |
| RU-SKI 43 is a small molecule inhibitor of Hhat(Hedgehog acyltransferase), the enzyme | ||||
| 6111413 | Roquinimex | 84088-42-6 | 98% |  |
| Roquinimex (Linomide; PNU212616; ABR212616) is a quinoline derivative immunostimulant | ||||
| 6111024 | RHPS4 | 390362-78-4 | 98% | |
| RHPS4 is a potent inhibitor of Telomerase at submicromolar. | ||||
| 611924 | RGB-286638 | 784210-87-3 | 98% |  |
| RGB-286638 is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin | ||||
| 611909 | RK-33 | 1070773-09-9 | 98% | |
| RK-33 is an RNA helicase inhibitor against DDX3, and inhibit its helicase activity.RK | ||||
| 1673101 | RO8994 | 1309684-94-3 | 98% |  |
| RO8994 is a potent and selective spiroindolinone MDM2 inhibitor for cancer therapy. | ||||
| 16071112 | RO5045337 | 939981-39-2 | 98% by HPLC |  |
| RO5045337, also known as R7112, RG7112, is a MDM2 antagonist with potential antineopl | ||||
| 16070103 | RSL 3 | 1219810-16-8 | 98% by HPLC | |
| RSL 3 | ||||
| 16062107 | (R) QuinoxP(R) | 866081-62-1 | 97% by HPLC | QuinoxP(R)-cas-866081-62-1.png) |
| (R) QuinoxP(R) | ||||
| 166154 | Ro41-1049(HCl) | 127500-84-9 | 98% by HPLC | -cas-127500-84-9.png) |
| Ro 41-1049 is an inhibitor of the enzyme monoamine oxidase type A(MAO-A). | ||||
| 16061501 | RS-1 | 312756-74-4 | 98% by HPLC |  |
| 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide;RAD51-stimulator | ||||
| 16060701 | Relugolix | 737789-87-6 | 98% by HPLC |  |
| Relugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH) | ||||
| 16060303 | RO31-8220 mesylate | 138489-18-6 | 98% by HPLC |  |
| Ro 31-8220 is a PKC-inhibitor, which inhibits stimulated fluid pinocytosis of human P | ||||
| 031003 | R112 | 575474-82-7 | 98% |  |
| R112 is an ATP-competitive inhibitor of Syk kinase with a Ki of 96 nM. R112 inhibits | ||||
| 031001 | Ro 46-2005 | 150725-87-4 | 98% |  |
| Ro 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist, inhibits | ||||
| 030909 | RAD140 | 1182367-47-0 | 98% |  |
| Coming soon! | ||||